Sponsor or institution
Clinical trials and research at Chengdu Kanghong Pharmaceutical Group Co., Ltd.
As of November 12, 2026, Find a Trial lists 5 clinical trials run by Chengdu Kanghong Pharmaceutical Group Co., Ltd. that are recruiting, in China. By phase: Phase 1/2 (2), Phase 3 (2), Phase 1 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 5Clinical trials
- 1Country
Newest trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Testing Wujia Yizhi Granules for Mild-to-Moderate Alzheimer's Dementia | Phase 3 | Fuzhou, Fujian | Recruiting | Aug 2, 2024 |
| Gene therapy for treating neovascular age-related macular degeneration | Phase 1/2 | Tianjin | Recruiting | Jun 13, 2024 |
| Testing Shugan Jieyu Capsule for Generalized Anxiety Disorder | Phase 3 | Beijing | Recruiting | Mar 16, 2023 |
| Gene therapy for age-related vision loss | Phase 1/2 | Beijing | Recruiting | Jan 5, 2023 |
| Testing KH617 for advanced solid tumors | Phase 1 | Beijing, Beijing Municipality | Recruiting | Dec 28, 2022 |
All recruiting trials (5)
-
Testing Wujia Yizhi Granules for Mild-to-Moderate Alzheimer's Dementia
This study is testing if Wujia Yizhi granules can help people with mild-to-moderate Alzheimer's dementia feel better compared to a placebo.
-
Gene therapy for treating neovascular age-related macular degeneration
This study is testing a new gene therapy for people with neovascular age-related macular degeneration to see if a single injection can provide long-lasting treatment and reduce the need for frequent eye injections.
-
Testing Shugan Jieyu Capsule for Generalized Anxiety Disorder
This study is testing if Shugan Jieyu Capsules can help people with generalized anxiety disorder feel better compared to a placebo.
-
Gene therapy for age-related vision loss
This study is testing a new gene therapy for people aged 50 to 85 with age-related vision loss to see if a single injection can help improve their eyesight and reduce the need for ongoing treatments.
-
Testing KH617 for advanced solid tumors
This study is testing an injectable treatment called KH617 to see if it is safe and tolerable for people with advanced solid tumors.
Quick answers
How many clinical trials run by Chengdu Kanghong Pharmaceutical Group Co., Ltd. are recruiting right now?
5, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
All of them have sites in China. Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1/2: 2, Phase 3: 2, Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.